Dupont De Nemours, INC

DuPont de Nemours, Inc. reported strong second quarter 2026 results, surpassing financial guidance and leading to an upward revision of its full-year 2026 financial outlook.

DuPont de Nemours, Inc. has completed a 1-for-3 reverse stock split of its common stock effective June 24, 2026.

DuPont de Nemours, Inc. announced its Board of Directors has approved a 1-for-3 reverse stock split, effective June 24, 2026, and reaffirmed its 2026 financial guidance.

DuPont de Nemours, Inc. announced strong first quarter 2026 results, exceeding guidance and raising full-year projections, driven by organic growth and operational execution.

DuPont de Nemours, Inc. announced the resignation of a Board member, Luke Kissam, effective April 14, 2026, due to his upcoming appointment as CEO of Corteva, Inc.

DuPont de Nemours, Inc. expects to close the previously announced sale of its aramids business to Arclin on April 1, 2026, having satisfied all regulatory conditions.

DuPont de Nemours, Inc. announced Q2 2026 results with a 4% increase in net sales driven by organic growth in both its Healthcare & Water Technologies and Diversified Industrials segments.

DuPont de Nemours, Inc. reported Q1 2026 results with net sales up 4% to $1.7 billion, driven by organic growth and favorable currency impacts, and announced the completion of its Aramids business divestiture.

DuPont reports a net loss for Q3 2025 driven by significant charges related to the Electronics spin-off and Aramids divestiture, while continuing operations show sales growth.

DuPont reports mixed Q2 2025 results with net sales up 3% driven by ElectronicsCo volume, but net income significantly down due to a goodwill impairment charge and higher separation costs, as it targets a November 1, 2025 spin-off of its Electronics business.

DuPont's Q1 2025 results reveal a net loss driven by a significant goodwill impairment charge, alongside revenue growth and continued progress towards the separation of its Electronics business.

DuPont reported a 4% increase in net sales for Q3 2024 and is progressing with its plan to separate into three independent companies.

DuPont completed major divestitures and acquisitions in 2025, realigning its portfolio towards Healthcare & Water Technologies and Diversified Industrials, while navigating significant legal and financial restructuring.

DuPont is set to separate its Electronics business by November 1, 2025, while retaining its Water business, marking a significant realignment of its strategic focus.

DuPont's 2023 annual report highlights strategic divestitures, significant share repurchases, and the impact of macroeconomic challenges on its financial performance.

DuPont CEO Lori Koch disclosed the withholding of shares for tax obligations and a minor reallocation of retirement plan assets.

DuPont de Nemours, Inc. SVP and CFO Antonella Franzen reported the withholding of 1,558.1826 shares to cover tax obligations related to vested restricted stock units.

DuPont de Nemours, Inc. Director Donald G. Macpherson reported a transaction involving the acquisition of common stock.

DuPont de Nemours, Inc. Director Frederick M. Lowery reported the acquisition of 800.2891 shares of common stock on May 29, 2026.

DuPont de Nemours, Inc. Director Alexander M. Cutler reported the acquisition of 1,032.63 shares of common stock on May 29, 2026.

DuPont de Nemours, Inc. Director Donald G. Macpherson acquired 4,030 shares of common stock as part of a compensation grant.

DuPont de Nemours, Inc. has issued its 2026 Proxy Statement detailing the upcoming Annual Meeting of Stockholders on May 21, 2026, outlining key proposals including director elections, executive compensation approval, auditor ratification, and a proposed reverse stock split.

DuPont de Nemours, Inc. announces its 2025 Annual Meeting of Stockholders to be held on May 22, 2025, with proxy materials available for review and voting.

DuPont's 2025 proxy statement details director nominees, executive compensation, and corporate governance practices, highlighting a focus on performance-based pay and alignment with stockholder interests.

DuPont de Nemours, Inc. has adjourned its 2024 Annual Meeting of Stockholders, initially scheduled for May 23, 2024, and will reconvene it on June 5, 2024.

DuPont de Nemours, Inc. announced a leadership transition with Lori D. Koch succeeding Edward D. Breen as CEO, Antonella B. Franzen appointed as CFO, and updates to director nominee biographies and executive compensation details.

DuPont de Nemours, Inc. is holding its annual stockholder meeting on May 23, 2024, and has provided details on how shareholders can vote on key proposals.

Vanguard Capital Management has filed a Schedule 13G reporting a 7.51% beneficial ownership stake in DuPont de Nemours Inc.

The Vanguard Group has amended its Schedule 13G filing for DuPont de Nemours Inc, reporting 0% beneficial ownership following an internal realignment that disaggregates reporting to subsidiaries.